{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:36:14Z","timestamp":1790512574759,"version":"4.1.0"},"reference-count":98,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T00:00:00Z","timestamp":1560816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.00665","type":"journal-article","created":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T05:20:07Z","timestamp":1560835207000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":125,"title":["MicroRNAs in Alzheimer\u2019s Disease: Diagnostic Markers or Therapeutic Agents?"],"prefix":"10.3389","volume":"10","author":[{"given":"Francesco","family":"Angelucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Cechova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Valis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Kuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Hort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/cns.13035","article-title":"A review of clinical treatment considerations of donepezil in severe Alzheimer\u2019s disease","volume":"24","author":"Adlimoghaddam","year":"2018","journal-title":"CNS Neurosci. Ther."},{"key":"B3","first-page":"365","article-title":"microRNA (miRNA) speciation in Alzheimer\u2019s disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF)","volume":"3","author":"Alexandrov","year":"2012","journal-title":"Int. J. Biochem. Mol. Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"616","DOI":"10.4103\/1673-5374.230276","article-title":"Synaptic dysfunction in Alzheimer\u2019s disease: the effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention","volume":"13","author":"Alifragis","year":"2018","journal-title":"Neural Regen. Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"114065","DOI":"10.18632\/oncotarget.23119","article-title":"MiR-124 acts as a target for Alzheimer\u2019s disease by regulating BACE1","volume":"8","author":"An","year":"2017","journal-title":"Oncotarget"},{"key":"B6","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s12031-014-0344-1","article-title":"Spontaneous running wheel improves cognitive functions of mouse associated with miRNA expressional alteration in hippocampus following traumatic brain injury","volume":"54","author":"Bao","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1074\/jbc.M807530200","article-title":"MicroRNA-298 and MicroRNA-328 regulate expression of mouse \u03b2-amyloid precursor protein-converting enzyme 1","volume":"284","author":"Boissonneault","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17060842","article-title":"MicroRNAs: key regulators in the central nervous system and their implication in neurological diseases","volume":"17","author":"Cao","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/B978-0-444-64076-5.00026-0","author":"Carmona","year":"2018","journal-title":"Neurogenetics, Part II"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3014","article-title":"MicroRNA expression data analysis to identify key miRNAs associated with Alzheimer\u2019s disease","volume":"20","author":"Chen","year":"2018","journal-title":"J. Gene Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/7027380","article-title":"Potential roles of exosomal MicroRNAs as diagnostic biomarkers and therapeutic application in Alzheimer\u2019s disease","volume":"2017","author":"Chen","year":"2017","journal-title":"Neural Plast."},{"key":"B13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s13238-012-2003-z","article-title":"Horizontal transfer of microRNAs: molecular mechanisms and clinical applications","volume":"3","author":"Chen","year":"2012","journal-title":"Protein Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1007\/s12035-015-9105-6","article-title":"Analysis of RNA from Alzheimer\u2019s disease post-mortem brain tissues","volume":"53","author":"Clement","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2018.00178","article-title":"Highlights in BACE1 inhibitors for Alzheimer\u2019s disease treatment","volume":"6","author":"Coimbra","year":"2018","journal-title":"Front. Chem."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00051","article-title":"Epigenetic alterations in hippocampus of SAMP8 senescent mice and modulation by voluntary physical exercise","volume":"6","author":"Cos\u00edn-Tom\u00e1s","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"5550","DOI":"10.1007\/s12035-016-0088-8","article-title":"Plasma miR-34a-5p and miR-545-3p as early biomarkers of Alzheimer\u2019s disease: potential and limitations","volume":"54","author":"Cos\u00edn-Tom\u00e1s","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11010-013-1567-0","article-title":"NPY modulates miR-30a-5p and BDNF in opposite direction in an in vitro model of Alzheimer disease: a possible role in neuroprotection","volume":"376","author":"Croce","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrg2916","article-title":"Small RNA sorting: matchmaking for Argonautes","volume":"12","author":"Czech","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197329","article-title":"Specific serum and CSF microRNA profiles distinguish sporadic behavioural variant of frontotemporal dementia compared with Alzheimer patients and cognitively healthy controls","volume":"13","author":"Denk","year":"2018","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nrd.2018.110","article-title":"Gene therapy for neurological disorders: progress and prospects","volume":"17","author":"Deverman","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag0481","article-title":"Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy","volume":"9","author":"DeVos","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3233\/JAD-160203","article-title":"MicroRNAs as therapeutic targets for Alzheimer\u2019s disease","volume":"53","author":"Di Meco","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/625659","article-title":"Serum MicroRNA profiles serve as novel biomarkers for the diagnosis of alzheimer\u2019s disease","volume":"2015","author":"Dong","year":"2015","journal-title":"Dis. Markers"},{"key":"B25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/978-1-4939-7558-7_19","article-title":"Cell-specific RNA quantification in human SN DA neurons from heterogeneous post-mortem midbrain samples by UV-laser microdissection and RT-qPCR","volume":"1723","author":"Duda","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.toxlet.2011.11.032","article-title":"The miR-124 regulates the expression of BACE1\/\u03b2-secretase correlated with cell death in Alzheimer\u2019s disease","volume":"209","author":"Fang","year":"2012","journal-title":"Toxicol. Lett."},{"key":"B27","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.neubiorev.2017.06.012","article-title":"Physical exercise as an epigenetic modulator of brain plasticity and cognition","volume":"80","author":"Fernandes","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.clinbiochem.2018.05.020","article-title":"Micro RNA as a potential blood-based epigenetic biomarker for Alzheimer\u2019s disease","volume":"58","author":"Fransquet","year":"2018","journal-title":"Clin. Biochem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2008","journal-title":"Genome Res."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2018.59.9.1096","article-title":"Inhibition of miR-128 abates A\u03b2-mediated cytotoxicity by targeting PPAR-\u03b3 via NF-\u03baB inactivation in primary mouse cortical neurons and Neuro2a Cells","volume":"59","author":"Geng","year":"2018","journal-title":"Yonsei Med. J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.mcn.2017.11.012","article-title":"miR-302\/367-induced neurons reduce behavioral impairment in an experimental model of Alzheimer\u2019s disease","volume":"86","author":"Ghasemi-Kasman","year":"2018","journal-title":"Mol. Cell. Neurosci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3233\/JAD-170343","article-title":"A 9-microRNA signature in serum serves as a noninvasive biomarker in early diagnosis of Alzheimer\u2019s disease","volume":"60","author":"Guo","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.2174\/1567205014666170829101016","article-title":"miRNAs in Alzheimer disease\u2014a therapeutic perspective","volume":"14","author":"Gupta","year":"2017","journal-title":"Curr. Alzheimer Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","article-title":"Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic","volume":"14","author":"Hampel","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00333","article-title":"MicroRNA let-7f-5p promotes bone marrow mesenchymal stem cells survival by targeting caspase-3 in Alzheimer disease model","volume":"12","author":"Han","year":"2018","journal-title":"Front. Neurosci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40478-017-0414-z","article-title":"Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer\u2019s disease","volume":"5","author":"Hara","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.24436","article-title":"Epigenetic mechanisms related to cognitive decline during aging","author":"Harman","year":"2019","journal-title":"J. Neurosci. Res."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196929","article-title":"Defensive effect of microRNA-200b\/c against amyloid-beta peptide-induced toxicity in Alzheimer\u2019s disease models","volume":"13","author":"Higaki","year":"2018","journal-title":"PLoS One"},{"key":"B39","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s12264-013-1348-5","article-title":"MicroRNA-98 induces an Alzheimer\u2019s disease-like disturbance by targeting insulin-like growth factor 1","volume":"29","author":"Hu","year":"2013","journal-title":"Neurosci. Bull."},{"key":"B40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.biopha.2017.05.060","article-title":"Simvastatin ameliorate memory deficits and inflammation in clinical and mouse model of Alzheimer\u2019s disease via modulating the expression of miR-106b","volume":"92","author":"Huang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13025","article-title":"A\u03b2 and the dementia syndrome: Simple versus complex perspectives","volume":"48","author":"Hunter","year":"2018","journal-title":"Eur. J. Clin. Invest."},{"key":"B42","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41583-018-0067-3","article-title":"Imaging the evolution and pathophysiology of Alzheimer disease","volume":"19","author":"Jagust","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"613","DOI":"10.14348\/molcells.2017.0096","volume":"40","author":"Jeong","year":"2017","journal-title":"Mol. Cells."},{"key":"B44","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.12659\/MSM.908765","article-title":"Micro-RNA-137 inhibits tau hyperphosphorylation in Alzheimer\u2019s disease and targets the CACNA1C gene in transgenic mice and human neuroblastoma SH-SY5Y cells","volume":"24","author":"Jiang","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"B45","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.pharmthera.2011.10.002","article-title":"MicroRNAs in neurodegenerative diseases and their therapeutic potential","volume":"133","author":"Junn","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00216-017-0632-z","article-title":"Advances in microRNA analysis","volume":"410","author":"Kalogianni","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.3390\/ijms19082323","article-title":"miRNA-34c overexpression causes dendritic loss and memory decline","volume":"19","author":"Kao","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/2211536604666150813152620","article-title":"A microRNA-BDNF negative feedback signaling loop in brain: implications for Alzheimer\u2019s disease","volume":"4","author":"Keifer","year":"2015","journal-title":"MicroRNA"},{"key":"B49","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3390\/nu9090927","volume":"9","author":"Khou","year":"2017","journal-title":"Nutrients"},{"key":"B50","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3233\/jad-130932.","article-title":"MicroRNAs in plasma and cerebrospinal fluid as potential markers for alzheimer\u2019s disease","volume":"39","author":"Kiko","year":"2014","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.bbadis.2016.06.001","article-title":"Are circulating microRNAs peripheral biomarkers for Alzheimer\u2019s disease","volume":"1862","author":"Kumar","year":"2016","journal-title":"Biochim. Biophys. Acta."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00041","article-title":"MicroRNA-455-3p as a potential biomarker for Alzheimer\u2019s disease: an update","volume":"10","author":"Kumar","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/bs.pmbts.2016.12.013","article-title":"MicroRNAs as peripheral biomarkers in aging and age-related diseases","volume":"146","author":"Kumar","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/srep34433","article-title":"Replenishment of microRNA-188-5p restores the synaptic and cognitive deficits in 5XFAD mouse model of Alzheimer\u2019s disease","volume":"6","author":"Lee","year":"2016","journal-title":"Sci. Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"B56","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ana.23588","article-title":"MiR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model","volume":"72","author":"Lee","year":"2012","journal-title":"Ann. Neurol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1002\/1873-3468.13182","article-title":"Noncoding RNAs in disease","volume":"592","author":"Lekka","year":"2018","journal-title":"FEBS Lett."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20180051","article-title":"miR-15b reduces amyloid-\u03b2 accumulation in SH-SY5Y cell line through targetting NF-\u03baB signaling and BACE1","volume":"38","author":"Li","year":"2018","journal-title":"Biosci. Rep."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00340","article-title":"Osthole stimulated neural stem cells differentiation into neurons in an Alzheimer\u2019s disease cell model via upregulation of microRNA-9 and rescued the functional impairment of hippocampal neurons in APP\/PS1 transgenic mice","volume":"11","author":"Li","year":"2017","journal-title":"Front. Neurosci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3892\/ijmm.2014.1780","article-title":"MicroRNA-384 regulates both amyloid precursor protein and \u03b2-secretase expression and is a potential biomarker for Alzheimer\u2019s disease","volume":"34","author":"Liu","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"31298","DOI":"10.1074\/jbc.M112.366336","article-title":"MicroRNA-153 physiologically inhibits expression of amyloid-\u03b2 precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients","volume":"287","author":"Long","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B62","doi-asserted-by":"publisher","first-page":"5184","DOI":"10.1074\/jbc.M113.518241","article-title":"MicroRNA-339-5p down-regulates protein expression of \u03b2-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects","volume":"289","author":"Long","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/JAD-160835","article-title":"MicroRNAs in human cerebrospinal fluid as biomarkers for Alzheimer\u2019s disease","volume":"55","author":"Lusardi","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neulet.2017.09.043","article-title":"MicroRNA-125b promotes neurons cell apoptosis and Tau phosphorylation in Alzheimer\u2019s disease","volume":"661","author":"Ma","year":"2017","journal-title":"Neurosci. Lett."},{"key":"B65","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.molcel.2007.07.015","article-title":"The microRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing","volume":"27","author":"Makeyev","year":"2007","journal-title":"Mol. Cell"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhy323","article-title":"Aging-related changes in cognition and cortical integrity are associated with serum expression of candidate microRNAs for Alzheimer disease","author":"Maldonado-Lasuncion","year":"2018","journal-title":"Cereb. Cortex."},{"key":"B67","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4103\/1673-5374.244784","article-title":"MicroRNAs as diagnostic and therapeutic tools for Alzheimer\u2019s disease: advances and limitations","volume":"14","author":"Martinez","year":"2019","journal-title":"Neural Regen. Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2017.03.004","article-title":"Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer\u2019s disease: an integrative review","volume":"156","author":"Millan","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/9084507","article-title":"The bioinformatic analysis of the dysregulated genes and microRNAs in entorhinal cortex, hippocampus, and blood for Alzheimer\u2019s disease","volume":"2017","author":"Pang","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"B70","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3233\/JAD-161127","article-title":"Biomarkers for early diagnosis of Alzheimer\u2019s disease in the oldest old: yes or no","volume":"58","author":"Paolacci","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/j.jmb.2019.01.046","article-title":"Emerging role of microRNAs in dementia","volume":"431","author":"Ramakrishna","year":"2019","journal-title":"J. Mol. Biol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.bbrc.2016.08.067","article-title":"A critical evaluation of neuroprotective and neurodegenerative microRNAs in Alzheimer\u2019s disease","volume":"483","author":"Reddy","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B73","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/bs.pmbts.2016.12.009","article-title":"MicroRNAs, aging, cellular senescence, and Alzheimer\u2019s disease","volume":"146","author":"Reddy","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010803","article-title":"CSF tau and the CSF tau\/ABeta ratio for the diagnosis of Alzheimer\u2019s disease dementia and other dementias in people with mild cognitive impairment (MCI)","volume":"3","author":"Ritchie","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuint.2017.08.007","article-title":"APP\/A\u03b2 structural diversity and Alzheimer\u2019s disease pathogenesis","volume":"110","author":"Roher","year":"2017","journal-title":"Neurochem. Int."},{"key":"B76","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1172\/JCI78421","article-title":"Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau","volume":"125","author":"Santa-Maria","year":"2015","journal-title":"J. Clin. Invest."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1007\/s12272-015-0648-x","article-title":"Involvement of inflammation in Alzheimer\u2019s disease pathogenesis and therapeutic potential of anti-inflammatory agents","volume":"38","author":"Shadfar","year":"2015","journal-title":"Arch. Pharm. Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1148\/radiol.12120010","article-title":"Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers","volume":"266","author":"Shaffer","year":"2013","journal-title":"Radiology"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-019-1500-y","article-title":"Systematic review of miRNA as biomarkers in Alzheimer\u2019s disease","author":"Swarbrick","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"P1010","DOI":"10.1016\/j.jalz.2017.06.1408","article-title":"MicroRNA expression in Alzheimer disease: a systematic review of the literature and meta-analysis","volume":"13","author":"Takousis","year":"2017","journal-title":"Alzheimers Dement."},{"key":"B81","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/WNR.0000000000000608","article-title":"Apolipoprotein E isotype-dependent modulation of microRNA-146a in plasma and brain","volume":"27","author":"Teter","year":"2016","journal-title":"Neuroreport"},{"key":"B82","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.yfrne.2009.08.001","article-title":"Fine-tuning the brain: MicroRNAs","volume":"31","author":"Vreugdenhil","year":"2010","journal-title":"Front. Neuroendocrinol."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/srep26697","article-title":"MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer\u2019s disease","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"B84","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.biopsych.2017.07.023","article-title":"A novel microRNA-124\/PTPN1 signal pathway mediates synaptic and memory deficits in Alzheimer\u2019s disease","volume":"83","author":"Wang","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"B85","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.yjmcc.2018.10.005","article-title":"Epigenetic upregulation of miR-126 induced by heat stress contributes to apoptosis of rat cardiomyocytes by promoting Tomm40 transcription","volume":"129","author":"Wang","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"868","DOI":"10.17219\/acem\/62915","article-title":"MicroRNA in cardiovascular biology and disease","volume":"26","author":"Wojciechowska","year":"2017","journal-title":"Adv. Clin. Exp. Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41582-018-0065-0","article-title":"FDA approves patisiran to treat hereditary transthyretin amyloidosis","volume":"14","author":"Wood","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1159\/000375236","article-title":"Circulating biomarker panels in Alzheimer\u2019s disease","volume":"61","author":"Zafari","year":"2015","journal-title":"Gerontology"},{"key":"B89","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cca.2018.05.039","article-title":"Circulating microRNAs as novel biomarkers of Alzheimer\u2019s disease","volume":"484","author":"Zendjabil","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"B90","doi-asserted-by":"publisher","first-page":"14919","DOI":"10.1523\/JNEUROSCI.1165-14.2014","article-title":"Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer\u2019s disease","volume":"34","author":"Zhang","year":"2014","journal-title":"J. Neurosci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.lfs.2018.06.011","article-title":"Emerging role of MicroRNAs in peripheral nerve system","volume":"207","author":"Zhang","year":"2018","journal-title":"Life Sci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s12038-017-9698-1","article-title":"miR-200a-3p promotes b-amyloid-induced neuronal apoptosis through down-regulation of SIRT1 in Alzheimer\u2019s disease","volume":"42","author":"Zhang","year":"2017","journal-title":"J. Biosci."},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011213","article-title":"The prognostic value of microRNA-183 in human cancers","volume":"97","author":"Zhang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"B94","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.neuro.2016.07.004","article-title":"MiR-214-3p attenuates cognition defects via the inhibition of autophagy in SAMP8 mouse model of sporadic Alzheimer\u2019s disease","volume":"56","author":"Zhang","year":"2016","journal-title":"Neurotoxicology."},{"key":"B95","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ebiom.2018.07.036","article-title":"Circular RNAs: promising biomarkers for human diseases","volume":"34","author":"Zhang","year":"2018","journal-title":"EBioMedicine"},{"key":"B96","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12035-013-8595-3","article-title":"Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer\u2019s disease (AD) and in primary human neuronal\u2013glial (HNG) cells","volume":"50","author":"Zhao","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1002\/jcb.26700","article-title":"Protective effects of microRNA-330 on amyloid \u03b2-protein production, oxidative stress, and mitochondrial dysfunction in Alzheimer\u2019s disease by targeting VAV1 via the MAPK signaling pathway","volume":"119","author":"Zhou","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"B98","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.brainresbull.2012.05.018","article-title":"MicroRNA-195 downregulates Alzheimer\u2019s disease amyloid-\u03b2 production by targeting BACE1","volume":"88","author":"Zhu","year":"2012","journal-title":"Brain Res. Bull."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00665\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T05:20:10Z","timestamp":1560835210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00665\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,18]]},"references-count":98,"alternative-id":["10.3389\/fphar.2019.00665"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.00665","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,18]]},"article-number":"665"}}